Skip to main content

Flumazenil Injection Shortage

Last Updated: January 31, 2017
Status: Resolved

Reason for the Shortage
    • Fresenius Kabi had flumazenil on shortage due to short-term manufacturing delays.
    • Mylan Institutional could not provide a reason for the shortage.
    • Sandoz discontinued flumazenil injection in 2015.
    • West-Ward stated the reason for the shortage is increased demand.
Available Products
    • Flumazenil injection, Fresenius Kabi, 0.1 mg/mL, 10 mL vial, 1 count, NDC 63323-0424-10
    • Flumazenil injection, Fresenius Kabi, 0.1 mg/mL, 5 mL vial, 10 count, NDC 63323-0424-05
    • Flumazenil injection, Mylan Institutional, 0.1 mg/mL, 10 mL vial, 10 count, NDC 67457-0444-10
    • Flumazenil injection, Mylan Institutional, 0.1 mg/mL, 5 mL vial, 10 count, NDC 67457-0447-53
    • Flumazenil injection, West-Ward, 0.1 mg/mL, 10 mL vial, 10 count, NDC 00143-9783-10
    • Flumazenil injection, West-Ward, 0.1 mg/mL, 5 mL vial, 10 count, NDC 00143-9784-10

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated January 31, 2017 by Elyse MacDonald, PharmD, MS, BCPS. Created June 15, 2015 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer